glp-1 medication interactions TrimRX Current Insights, Advantages and Challenges
Description
FDA Approves Orforglipron For Chronic Weight Management
Compared to general practice, the more frequent and structured use of RDNs and MNT in these trials could be one reason why these trials demonstrated larger weight reductions than seen in real-world GLP-1 utilization for obesity
While these results are promising, the sample sizes are very small, and further studies are warranted to support these findings
Additionally, canagliflozin induced apoptosis in thyroid cancer cells
What Nutrients Should GLP-1 Users Prioritize
